Alector Ownership | Who Owns Alector?
Alector Ownership Summary
Alector is owned by 7.19% institutional investors, 10.12% insiders, and 82.69% retail investors. Fmr is the largest institutional shareholder, holding 15.13% of ALEC shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.32% of its assets in Alector shares.
ALEC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alector | 7.19% | 10.12% | 82.69% |
| Sector | Healthcare Stocks | 232.63% | 10.66% | -143.29% |
| Industry | Biotech Stocks | 382.12% | 10.42% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 15.18M | 15.13% | $44.94M |
| Blackrock | 9.10M | 9.70% | $41.32M |
| Blackrock funding, inc. /de | 7.15M | 6.97% | $11.15M |
| Rtw investments, lp | 6.99M | 6.96% | $20.69M |
| Vanguard group | 6.91M | 6.73% | $10.78M |
| Merck | 3.55M | 3.53% | $10.50M |
| Acadian asset management | 3.44M | 3.36% | $5.36M |
| Price t rowe associates inc /md/ | 2.19M | 2.18% | $6.47M |
| Geode capital management | 2.08M | 2.02% | $3.24M |
| State street | 1.73M | 1.73% | $5.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Merck | 3.55M | 4.60% | $10.50M |
| New leaf venture partners | 339.57K | 2.33% | $1.01M |
| Euclidean capital | 1.31M | 1.63% | $3.87M |
| 5am venture management | 995.84K | 1.08% | $2.95M |
| Medici capital | 481.97K | 1.03% | $1.43M |
| Dafna capital management | 798.35K | 0.58% | $2.36M |
| Eversept partners, lp | 1.49M | 0.30% | $4.41M |
| Nano cap new millennium growth fund l p | 200.00K | 0.27% | $312.00M |
| Rtw investments, lp | 6.99M | 0.26% | $20.69M |
| Ikarian capital | 760.00K | 0.23% | $2.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 6.99M | 0.26% | 6.99M |
| Acadian asset management | 3.44M | 0.01% | 1.07M |
| 683 capital management | 1.00M | 0.15% | 1.00M |
| Vanguard group | 6.91M | 0.00% | 873.39K |
| Jane street group | 993.91K | 0.00% | 643.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -9.70M |
| Deep track capital, lp | - | - | -4.63M |
| Ecor1 capital | - | - | -4.06M |
| Price t rowe associates inc /md/ | 2.19M | 0.00% | -2.69M |
| Braidwell lp | - | - | -2.16M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rtw investments, lp | 6.99M | 0.26% | 6.99M | $20.69M |
| 683 capital management | 1.00M | 0.15% | 1.00M | $2.96M |
| Nano cap new millennium growth fund l p | 200.00K | 0.27% | 200.00K | $312.00M |
| Artia global partners lp | 71.03K | 0.03% | 71.03K | $210.25K |
| Sg americas securities | 27.00K | 0.00% | 27.00K | $42.00K |
Sold Out
| Holder | Change |
|---|---|
| Sandy spring bank | -1.00 |
| Truvestments capital | -2.00 |
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Parallel advisors | -15.00 |
| Farther finance advisors | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | -87.82% | 7,374,102 | -90.14% | 7 | 0.13% | 7 | -90.41% | 7 | -82.50% |
| Sep 30, 2025 | 48 | -64.71% | 8,400,791 | -88.08% | 8 | 0.17% | 17 | -73.02% | 13 | -64.86% |
| Jun 30, 2025 | 134 | -5.63% | 70,260,765 | -3.24% | 70 | 1.31% | 60 | -7.69% | 38 | 11.76% |
| Mar 31, 2025 | 13 | -91.45% | 16,026,504 | -78.15% | 16 | 0.28% | 7 | -90.67% | 1 | -97.37% |
| Dec 31, 2024 | 149 | -9.15% | 73,332,095 | 1.08% | 75 | 1.35% | 73 | 7.35% | 38 | -20.83% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.38M | 5.32% | 7.10K |
| Fidelity Growth Compy Commingled Pl O | 5.02M | 5.16% | 13.10K |
| Fidelity Growth Company Fund | 3.70M | 3.66% | -22.17K |
| T. Rowe Price Health Sciences | 3.13M | 3.09% | -661.48K |
| Vanguard US Total Market Shares ETF | 2.37M | 2.39% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.54M | 2.30% | - |
| Fidelity Select Biotechnology | 2.22M | 2.01% | - |
| iShares Russell 2000 ETF | 1.89M | 1.72% | 570.92K |
| Fidelity Growth Company K6 | 1.27M | 1.26% | 15.32K |
| Fidelity Series Growth Company | 999.46K | 0.99% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Wong-Sarad Grace | Principal Accounting Officer | Sell | $2.65K |
| Mar 03, 2026 | Wong-Sarad Grace | Principal Accounting Officer | Sell | $7.01K |
| Mar 02, 2026 | Wong-Sarad Grace | Principal Accounting Officer | Sell | $17.14K |
| Mar 02, 2026 | Rosenthal Arnon | Chief Executive Officer | Sell | $173.82K |
| Mar 02, 2026 | Berkley Neil Lindsay | CFO & Chief Business Officer | Sell | $62.95K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 6 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 4 |
ALEC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools